Personalised exhaled nitric oxygen fraction (F ENO)-driven asthma management in primary care: a F ENO subgroup analysis of the ACCURATE trial.

Suzanne BoerPersijn J HonkoopRik J B LoijmansJiska B Snoeck-StrobandWillem J J AssendelftTjard Ronald Jacob SchermerJacob K Sont

Published in: ERJ open research (2020)

In primary care, F ENO-driven asthma management is effective in patients with a low F ENO level, for whom it is possible to down-titrate medication, while preserving asthma control and quality of life.

Keyphrases

primary care
chronic obstructive pulmonary disease
lung function
allergic rhinitis
phase iii
clinical trial
healthcare
study protocol
general practice
high resolution
emergency department
randomized controlled trial
cystic fibrosis
phase ii
mass spectrometry
adverse drug